Partnership aims to bring AI imaging solutions to Africa

Michael Walter | | Health Exec | Economics

Oxipit, a Lithuania-based medical imaging solutions manufacturer, and Healthcare Konnect, a Swiss distribution company, have announced a new partnership focused on delivering AI imaging solutions to Nigeria.

The two companies will work together to share Oxipit’s ChestEye AI imaging suite with healthcare providers. ChestEye AI was designed to improve the detection of 75 different findings.

Nigeria is currently experiencing a severe radiologist shortage, with an estimated 400 specialists available to serve the area’s more than 200 million people. The Association of Radiologists of Nigeria has worked to promote this issue.

“We are eager to support radiologists in improving diagnostics in both rural and heavily populated regions of Africa,” Marwan Senhaji, managing director of HealthCare Konnect, said in a prepared statement.

Gediminas Peksys, Oxipit’s CEO, said the company is “excited to introduce AI capabilities of our imaging suite in Nigeria, where improvements in diagnostics can bring significant benefits for patient care.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.